Clinical Trial Update: Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating the efficacy of omega-3 fatty acids for Borderline personality disorder; the current status of the study is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Borderline Personality Disorder. | Phase 4 | Status: UNKNOWN